Sunday was National Cancer Survivors Day. Last week’s articles on Protection Guru were the right week to read in the run-up. Two on cancer itself, looking at survival, daily life, work and the financial reality. Two on rare surgeries where the wording on the policy schedule does not always meet modern medicine in the middle.
In Cancer survival in the UK and its impact on daily life and work (Part One), we get a clear picture of what cancer in the UK actually looks like today. Four cancers account for more than half of new UK diagnoses each year. Breast cancer is the commonest in women, with around 59,000 new cases a year and ten-year survival between 75 and 78%. Prostate is the commonest in men, with ten-year survival between 78 and 84%. Lung is the brutal outlier, with one in ten reaching ten years. The numbers are only half the story. Fatigue persists for months or years after treatment. Cognitive symptoms patients call chemo brain blunt memory and concentration. Cancer is treated as a disability under the Equality Act from the point of diagnosis. The average breast cancer patient takes around six months off work. Some return part-time. Some do not return at all.
In Protecting against the financial impact of cancer: The role of Critical Illness and Income Protection (Part Two), the financial side comes into focus. The Critical Illness (CI) lump sum lands at the worst possible time, which is also where it is most useful. A full payment under most modern policies settles the claim and ends the cover. For carcinoma in situ and similar early-stage disease, an additional payment of typically 25% is made and the original cover continues. The article presses home that CI handles the moment of diagnosis. Income Protection (IP) handles the months and sometimes years that follow. A woman whose company sick pay runs out three months into chemotherapy. A man returning to a physical job part-time after bowel surgery. A survivor whose mental health is preventing a return to work years after remission. Recommending CI without IP for cancer tends to leave a gap, and the gap is rarely small.
In Pleurectomy: The Rare Lung Surgery That Makes Vitality Different, we step into one of those wordings on the longer condition lists that most advisers have never come across. A pleurectomy is the surgical removal of the membrane wrapped around the lung, performed either for malignant mesothelioma (a cancer with a long latency from historical asbestos exposure) or for non-malignant disease such as recurrent pneumothorax in younger patients. Vitality is the only UK insurer with a named clause for the procedure on its Serious Illness Cover. The mesothelioma cases almost never trigger the clause, because the main cancer wording has already paid. The patients the clause actually pays for are the younger non-malignant cases, often men in their twenties with repeated lung collapse, who under almost any other CI policy would have no route to a claim for this surgery.
In Congenital Heart Disease in Critical Illness Insurance: Wordings, Claims and Modern Treatment Challenges, the same theme appears in a different shape. Congenital heart disease affects around 1 in 150 UK live births. The standard CI structural heart wording is built around open-heart surgery through a sternotomy. Over the last two decades, much of paediatric and adult congenital cardiology has moved from open surgery to catheter-based intervention through a vein in the groin. The chest is not opened. The standard wording does not pay. Vitality is again the named exception, with explicit cover for catheter-based atrial or ventricular septal defect closure that other insurers generally do not match. For a client whose child is scheduled for catheter closure of a hole in the heart, the choice of insurer at recommendation directly shapes whether the claim pays at all.
There is a straight line across all four pieces. The cancer pair sets out where the claim begins and what happens afterwards. The surgery pair sets out where modern medicine has moved beyond what the wording was built around. In every case, the lump sum and the procedure are the start of the story, not the end of it. The adviser whose recommendation accounts for the long tail is the adviser whose clients are still supported when treatment has long stopped.
CI pays once, in a moment, on a definition. The lived consequences run for years. Fortunately, Protection Guru exists to give you the detail on both sides of that line. Make sure you read all the above articles in full using the links above.
We produce our Protection Guru Digital Directory as the ultimate protection technical guide for advisers, tying every awareness day and clinical condition back to the policy realities.
For most working-age clients with cancer, the strongest protection setup is CI and IP working together. The lump sum buys time at diagnosis. The income carries the household through the long tail of treatment, recovery and the mental health work that often follows. If you have not yet seen how Protection Guru Pro handles that combined recommendation in practice, the Income Protection demo is a useful starting point. It is the difference between selling cover and recommending the right one.
